LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LONA is expected to report earnings to fall 35.26% to -112 cents per share on August 17
Q2'26
Est.
$-1.12
Q1'26
Missed
by $1.54
Q4'25
Missed
by $18.80
The last earnings report on May 07 showed earnings per share of -173 cents, missing the estimate of -18 cents. With 1.40K shares outstanding, the current market capitalization sits at 77.68M.